# Boulder Ventures

> Boulder Ventures is a VC fund backing Software and Information Technology. See 111 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Boulder, United States
- Total investments: 111
- Last investment: Mar 2026
- Lead investor: 23%
- Fund size: $58M
- Last fund: Dec 2022
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/boulder-ventures/
- X (Twitter): https://twitter.com/boulderVC
- Website: http://www.boulderventures.com

Boulder Ventures is a VC fund in Boulder focused on Software and Information Technology. Boulder Ventures invests in early stage information technology and life science companies in Colorado and the Mid-Atlantic.

## Contacts

5 contacts available for Boulder Ventures. Shizune tracks 8 team members at Boulder Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/boulder-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 21 | 19% |
| Information Technology | 13 | 12% |
| Biotechnology | 10 | 9% |
| Enterprise Software | 9 | 8% |
| Analytics | 8 | 7% |

92 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 28 | 25% |
| Series B | 22 | 20% |
| Funding Round | 18 | 16% |
| Series C | 11 | 10% |
| Seed | 8 | 7% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 55 | 50% |
| China | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bill Karpovich | Boulder Ventures | 1 | https://shizune.co/investors/profile/bill-karpovich |
| James Dudley | Principal | 0 | https://shizune.co/investors/profile/james-dudley-8f95 |
| Jonathan Perl | General Partner | 11 | https://shizune.co/investors/profile/jonathan-perl-2 |
| Josh Fidler | Founding Partner | 3 | https://shizune.co/investors/profile/josh-fidler |
| Kishen Mangat | General Partner | 2 | https://shizune.co/investors/profile/kishen-mangat |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ambrosia Biosciences | Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | $100M | Series B | Mar 31, 2026 |  |
| Comeryx | Comeryx is a tailored AI platform that is specially designed for small businesses for a seamless experiences. | $7.5M | Seed | Feb 18, 2026 |  |
| RAPIDFORT | RapidFort provides software supply chain security solutions focused on identifying, prioritizing, and remediating vulnerabilities in containerized applications without requiring code changes. The company’s platform combines curated near-zero CVE container images, automated scanning, profiling, and runtime protection tools to manage software attacksurfaces and support compliance workflows. RapidFort’s technology generates software bills of materials and runtime insights to help teams reduce exposure to vulnerabilities across the development lifecycle and integrate security into existing CI/CD processes. The platform is designed to assist engineering and security teams in streamlining vulnerability management and optimizing container security at scale. | $42M | Series A | Feb 03, 2026 |  |
| Synaptic | Synaptic is a longstanding Salesforce partner, recognized for its proven track record of delivering customer success. | $5M | Seed | Jun 26, 2025 |  |
| RAPIDFORT | RapidFort provides software supply chain security solutions focused on identifying, prioritizing, and remediating vulnerabilities in containerized applications without requiring code changes. The company’s platform combines curated near-zero CVE container images, automated scanning, profiling, and runtime protection tools to manage software attacksurfaces and support compliance workflows. RapidFort’s technology generates software bills of materials and runtime insights to help teams reduce exposure to vulnerabilities across the development lifecycle and integrate security into existing CI/CD processes. The platform is designed to assist engineering and security teams in streamlining vulnerability management and optimizing container security at scale. |  | Seed | Jun 20, 2025 |  |
| Opanga Networks | Opanga Networks specializes in delivering machine learning-powered network modernization. The company is an innovator of machine learning technology deployed in its optimization and data science applications across all network types and sizes. Its ML applications enable more efficient network CAPEX/OPEX investments, a smaller carbon footprint,deeper network insights, and improved consumer experience. |  |  | Apr 15, 2025 |  |
| Ambrosia Biosciences | Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | $25M | Series A | Dec 10, 2024 |  |
| RAPIDFORT | RapidFort provides software supply chain security solutions focused on identifying, prioritizing, and remediating vulnerabilities in containerized applications without requiring code changes. The company’s platform combines curated near-zero CVE container images, automated scanning, profiling, and runtime protection tools to manage software attacksurfaces and support compliance workflows. RapidFort’s technology generates software bills of materials and runtime insights to help teams reduce exposure to vulnerabilities across the development lifecycle and integrate security into existing CI/CD processes. The platform is designed to assist engineering and security teams in streamlining vulnerability management and optimizing container security at scale. |  | Seed | Aug 27, 2024 |  |
| Symmera | Symmera offers cutting-edge solutions for corporate digitization. Symmera allows a safe communications field and trustworthy data transfers between devices and microservices. |  | Seed | Aug 21, 2024 |  |
| Ambrosia Biosciences | Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | $16M | Series A | Aug 06, 2024 |  |

10 of 111 investments shown.

## Co-investors
- [Grotech Ventures](https://shizune.co/investors/profile/grotech-ventures) — VC Fund, 9 deals together
- [Vista Ventures](https://shizune.co/investors/profile/vista-ventures) — VC Fund, 8 deals together
- [Intersouth Partners](https://shizune.co/investors/profile/intersouth-partners) — VC Fund, 6 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 6 deals together
- [Sequel Venture Partners](https://shizune.co/investors/profile/sequel) — VC Fund, 6 deals together
- [Remeditex Ventures](https://shizune.co/investors/profile/remeditex-ventures) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Infrastructure VC Funds](https://shizune.co/investors/infrastructure-vc-funds)
- [Infrastructure Investors in United States](https://shizune.co/investors/infrastructure-investors-united-states)
- [Infrastructure VC Funds in United States](https://shizune.co/investors/infrastructure-vc-funds-united-states)
- [Infrastructure Investors](https://shizune.co/investors/infrastructure-investors)

## FAQ

### What does Boulder Ventures invest in?

Boulder Ventures invests primarily in Software, Information Technology and Biotechnology startups, most often at Series A and Series B stage. Most of the 111 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Boulder Ventures?

Public channels for Boulder Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Boulder Ventures?

The team at Boulder Ventures includes Bill Karpovich (Boulder Ventures), James Dudley (Principal) and Jonathan Perl (General Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co